1,810 reports of this reaction
17.3% of all BRIVARACETAM reports
#1 most reported adverse reaction
SEIZURE is the #1 most commonly reported adverse reaction for BRIVARACETAM, manufactured by Apotex Corp.. There are 1,810 FDA adverse event reports linking BRIVARACETAM to SEIZURE. This represents approximately 17.3% of all 10,449 adverse event reports for this drug.
Patients taking BRIVARACETAM who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is a frequently reported adverse event for BRIVARACETAM, accounting for a significant proportion of all reports.
In addition to seizure, the following adverse reactions have been reported for BRIVARACETAM:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 1,810 FDA reports for BRIVARACETAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 17.3% of all adverse event reports for BRIVARACETAM, making it one of the most commonly reported side effect.
If you experience seizure while taking BRIVARACETAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.